DNAR PANEL Trademark

Trademark Overview

On Friday, March 2, 2007, a trademark application was filed for DNAR PANEL with the United States Patent and Trademark Office. The USPTO has given the DNAR PANEL trademark a serial number of 77121047. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 14, 2011. This trademark is owned by DNAR Inc.. The DNAR PANEL trademark is filed in the Pharmaceutical Products category with the following description:

Molecular diagnostic tests comprised of antibodies and other reagents to guide cancer treatment
dnar panel

General Information

Serial Number77121047
Word MarkDNAR PANEL
Filing DateFriday, March 2, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 14, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 20, 2007

Trademark Statements

Disclaimer with Predetermined Text"PANEL"
Goods and ServicesMolecular diagnostic tests comprised of antibodies and other reagents to guide cancer treatment

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 8, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDNAR Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02215
Party NameDNAR Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02215

Trademark Events

Event DateEvent Description
Monday, March 14, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 14, 2011ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 17, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, August 16, 2010EXTENSION 5 GRANTED
Friday, August 6, 2010EXTENSION 5 FILED
Friday, August 6, 2010TEAS EXTENSION RECEIVED
Tuesday, February 16, 2010EXTENSION 4 GRANTED
Monday, February 8, 2010EXTENSION 4 FILED
Monday, February 8, 2010TEAS EXTENSION RECEIVED
Friday, September 4, 2009EXTENSION 3 GRANTED
Friday, August 7, 2009EXTENSION 3 FILED
Thursday, September 3, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 7, 2009TEAS EXTENSION RECEIVED
Monday, February 2, 2009EXTENSION 2 GRANTED
Monday, February 2, 2009EXTENSION 2 FILED
Monday, February 2, 2009TEAS EXTENSION RECEIVED
Monday, August 11, 2008EXTENSION 1 GRANTED
Monday, August 11, 2008EXTENSION 1 FILED
Monday, August 11, 2008TEAS EXTENSION RECEIVED
Tuesday, February 12, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 20, 2007PUBLISHED FOR OPPOSITION
Wednesday, October 31, 2007NOTICE OF PUBLICATION
Tuesday, October 16, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 16, 2007ASSIGNED TO LIE
Saturday, September 15, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 8, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, September 8, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 8, 2007TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, August 31, 2007FINAL REFUSAL MAILED
Friday, August 31, 2007FINAL REFUSAL WRITTEN
Tuesday, August 7, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 7, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 7, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 22, 2007NON-FINAL ACTION MAILED
Thursday, June 21, 2007NON-FINAL ACTION WRITTEN
Wednesday, June 20, 2007ASSIGNED TO EXAMINER
Saturday, June 16, 2007ASSIGNED TO EXAMINER
Wednesday, March 7, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

panel dnar reagents guide cancer treatment other antibodies diagnostic tests comprised molecular